Your browser doesn't support javascript.
loading
Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody-Drug Conjugate Modifications.
Linz, Thomas; Yeo, Dominick; Hong, Qiuting; Zmolek, Wesley; McFarland, Jesse; Barfield, Robyn M; Haskins, William E; Rabuka, David.
Afiliação
  • Linz T; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. thomas.linz@catalent.com.
  • Yeo D; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. dominick.yeo@catalent.com.
  • Hong Q; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. qiuting.hong@catalent.com.
  • Zmolek W; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. wesley.zmolek@catalent.com.
  • McFarland J; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. jesse.mcfarland@catalent.com.
  • Barfield RM; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. robyn.barfield@catalent.com.
  • Haskins WE; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. william.haskins@catalent.com.
  • Rabuka D; Catalent Biologics, 2600 Hilltop Drive, Richmond, CA 94806, USA. david.rabuka@catalent.com.
Antibodies (Basel) ; 7(4)2018 Nov 16.
Article em En | MEDLINE | ID: mdl-31544890

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article